NCT02983708View on ClinicalTrials.gov

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
NeurodegenerationG-CSFPeripheral Blood Mononuclear CellsCerebral Palsy
Interventions
BIOLOGICAL

Peripheral blood mononuclear cells (mPBMC)

DRUG

G-CSF

DRUG

Placebo

All Listed Sponsors
collaborator

Ministry of Health & Welfare, Korea

OTHER_GOV

lead

Hanyang University Seoul Hospital

OTHER

NCT02983708 - Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells | Biotech Hunter | Biotech Hunter